KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Change in Account Payables (2016 - 2025)

Gilead Sciences' Change in Account Payables history spans 17 years, with the latest figure at -$95.0 million for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 63.79% year-over-year to -$95.0 million; the TTM value through Dec 2025 reached -$132.0 million, down 145.52%, while the annual FY2025 figure was -$132.0 million, 145.52% down from the prior year.
  • Change in Account Payables reached -$95.0 million in Q4 2025 per GILD's latest filing, down from $230.0 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $359.0 million in Q3 2024 to a low of -$272.0 million in Q1 2023.
  • Average Change in Account Payables over 5 years is -$4.0 million, with a median of -$24.5 million recorded in 2021.
  • The largest YoY upside for Change in Account Payables was 1337.93% in 2024 against a maximum downside of 2666.67% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at $124.0 million in 2021, then skyrocketed by 112.9% to $264.0 million in 2022, then tumbled by 116.29% to -$43.0 million in 2023, then crashed by 34.88% to -$58.0 million in 2024, then tumbled by 63.79% to -$95.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Change in Account Payables are -$95.0 million (Q4 2025), $230.0 million (Q3 2025), and -$162.0 million (Q2 2025).